{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:29:38Z","timestamp":1793831378536,"version":"4.6.1"},"reference-count":73,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Cardiovascular Medicine"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.tcm.2025.01.002","type":"journal-article","created":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T04:01:34Z","timestamp":1737691294000},"page":"271-281","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Atrial fibrillation versus atrial myopathy in thrombogenesis: Two sides of the same coin?"],"prefix":"10.1016","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4691-7183","authenticated-orcid":false,"given":"Panteleimon E.","family":"Papakonstantinou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Miguel","family":"Rivera-Caravaca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Chiarito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanne","family":"Ehrlinder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panayiotis","family":"Iliakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"G\u0105secka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio Francesco","family":"Romiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William A.E.","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory Y.H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tcm.2025.01.002_bib0001","article-title":"Atrial fibrillation: epidemiology, screening and digital health","volume":"37","author":"Linz","year":"2024","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.tcm.2025.01.002_bib0002","author":"Goette","year":"2024","journal-title":"Europace"},{"issue":"5","key":"10.1016\/j.tcm.2025.01.002_bib0003","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.jacbts.2019.05.005","article-title":"Atrial Myopathy","volume":"4","author":"Shen","year":"2019","journal-title":"JACC Basic Transl Sci"},{"issue":"10","key":"10.1016\/j.tcm.2025.01.002_bib0004","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1093\/europace\/euw161","article-title":"EHRA\/HRS\/APHRS\/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication","volume":"18","author":"Goette","year":"2016","journal-title":"Europace"},{"key":"10.1016\/j.tcm.2025.01.002_bib0005","author":"Van Gelder","year":"2024","journal-title":"Eur Heart J"},{"issue":"20","key":"10.1016\/j.tcm.2025.01.002_bib0006","doi-asserted-by":"crossref","DOI":"10.1161\/CIR.0000000000000568","article-title":"Atrial fibrillation burden: mmoving beyond Atrial fibrillation as a binary entity: a scientific statement from the American Heart Association","volume":"137","author":"Chen","year":"2018","journal-title":"Circulation"},{"issue":"21","key":"10.1016\/j.tcm.2025.01.002_bib0007","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1161\/CIRCULATIONAHA.113.007825","article-title":"Temporal relationship between subclinical atrial fibrillation and embolic events","volume":"129","author":"Brambatti","year":"2014","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.tcm.2025.01.002_bib0008","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s00392-017-1123-0","article-title":"Clinical scores for outcomes of rhythm control or arrhythmia progression in patients with atrial fibrillation: a systematic review","volume":"106","author":"Deng","year":"2017","journal-title":"Clin Res Cardiol"},{"issue":"13","key":"10.1016\/j.tcm.2025.01.002_bib0009","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1056\/NEJMoa2303062","article-title":"Anticoagulation with Edoxaban in patients with atrial high-rate episodes","volume":"389","author":"Kirchhof","year":"2023","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.tcm.2025.01.002_bib0010","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa2310234","article-title":"Apixaban for stroke prevention in subclinical atrial fibrillation","volume":"390","author":"Healey","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tcm.2025.01.002_bib0011","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","author":"Van Gelder","year":"2024","journal-title":"Eur Heart J"},{"issue":"22","key":"10.1016\/j.tcm.2025.01.002_bib0012","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1016\/j.jacc.2007.07.076","article-title":"Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy","volume":"50","author":"Hohnloser","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.tcm.2025.01.002_bib0013","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehu307","article-title":"Risk of ischaemic stroke according to pattern of atrial fibrillation: analysis of 6563 aspirin-treated patients in ACTIVE-A and AVERROES","volume":"36","author":"Vanassche","year":"2015","journal-title":"Eur Heart J"},{"issue":"20","key":"10.1016\/j.tcm.2025.01.002_bib0014","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1093\/eurheartj\/ehw007","article-title":"The impact of atrial fibrillation type on the risk of thromboembolism, mortality, and bleeding: a systematic review and meta-analysis","volume":"37","author":"Ganesan","year":"2016","journal-title":"Eur Heart J"},{"issue":"9","key":"10.1016\/j.tcm.2025.01.002_bib0015","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.amjcard.2012.06.034","article-title":"Detection of previously undiagnosed atrial fibrillation in patients with stroke risk factors and usefulness of continuous monitoring in primary stroke prevention","volume":"110","author":"Ziegler","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.tcm.2025.01.002_bib0016","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ejim.2022.06.023","article-title":"Epidemiology of subclinical atrial fibrillation in patients with cardiac implantable electronic devices: a systematic review and meta-regression","volume":"103","author":"Proietti","year":"2022","journal-title":"Eur J Intern Med"},{"issue":"22","key":"10.1016\/j.tcm.2025.01.002_bib0017","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.022487","article-title":"Atrial high-rate episode duration thresholds and thromboembolic risk: a systematic review and meta-analysis","volume":"10","author":"Sagris","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.tcm.2025.01.002_bib0018","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ijcard.2022.09.046","article-title":"Atrial high-rate episode burden and stroke risks for patients with device-detected subclinical atrial fibrillation: a systematic review and meta-analysis","volume":"371","author":"Meng","year":"2023","journal-title":"Int J Cardiol"},{"issue":"3","key":"10.1016\/j.tcm.2025.01.002_bib0019","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1161\/01.CIR.95.3.562","article-title":"Atrial fibrillation. A tachycardia-induced atrial cardiomyopathy","volume":"95","author":"Zipes","year":"1997","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.tcm.2025.01.002_bib0020","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1001\/jamacardio.2024.1528","article-title":"Rare and common genetic variation underlying atrial fibrillation risk","volume":"9","author":"Vad","year":"2024","journal-title":"JAMA Cardiol"},{"issue":"2","key":"10.1016\/j.tcm.2025.01.002_bib0021","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00395-024-01038-0","article-title":"Pathophysiology and clinical relevance of atrial myopathy","volume":"119","author":"Tubeeckx","year":"2024","journal-title":"Basic Res Cardiol"},{"issue":"7","key":"10.1016\/j.tcm.2025.01.002_bib0022","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.015343","article-title":"Characterization, pathogenesis, and clinical implications of inflammation-related atrial myopathy as an important cause of atrial fibrillation","volume":"9","author":"Packer","year":"2020","journal-title":"J Am Heart Assoc"},{"issue":"12","key":"10.1016\/j.tcm.2025.01.002_bib0023","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1161\/CIRCEP.123.003750","article-title":"Genetic atrial cardiomyopathies: common features, specific differences, and broader relevance to understanding atrial cardiomyopathy","volume":"16","author":"Marcoux","year":"2023","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"12","key":"10.1016\/j.tcm.2025.01.002_bib0024","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1001\/jamacardio.2021.3370","article-title":"Early-onset atrial fibrillation and the prevalence of rare variants in cardiomyopathy and arrhythmia genes","volume":"6","author":"Yoneda","year":"2021","journal-title":"JAMA Cardiol"},{"issue":"7","key":"10.1016\/j.tcm.2025.01.002_bib0025","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1001\/jamacardio.2022.0810","article-title":"Mortality among patients with early-onset atrial fibrillation and rare variants in cardiomyopathy and arrhythmia genes","volume":"7","author":"Yoneda","year":"2022","journal-title":"JAMA Cardiol"},{"issue":"1","key":"10.1016\/j.tcm.2025.01.002_bib0026","first-page":"57","article-title":"Atrial standstill in the pediatric population: a Multi-institution collaboration","volume":"9","author":"Howard","year":"2023","journal-title":"JACC: Clin Electrophysiol"},{"key":"10.1016\/j.tcm.2025.01.002_bib0027","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2023.1149717","article-title":"Case report: mutation in NPPA gene as a cause of fibrotic atrial myopathy","volume":"10","author":"Silva Cunha","year":"2023","journal-title":"Front Cardiovasc Med"},{"issue":"10","key":"10.1016\/j.tcm.2025.01.002_bib0028","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1001\/jamaneurol.2022.3031","article-title":"Severity and etiology of incident stroke in patients screened for atrial fibrillation vs usual care and the impact of prior stroke: a post hoc analysis of the LOOP randomized clinical trial","volume":"79","author":"Diederichsen","year":"2022","journal-title":"JAMA Neurol"},{"issue":"2","key":"10.1016\/j.tcm.2025.01.002_bib0029","first-page":"164","article-title":"Associations between diagnosis with stroke, comorbidities, and activity of daily living among older adults in the United States","volume":"9","author":"Ruksakulpiwat","year":"2023","journal-title":"Chronic Dis Transl Med"},{"issue":"23","key":"10.1016\/j.tcm.2025.01.002_bib0030","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1056\/NEJMoa021328","article-title":"A comparison of rate control and rhythm control in patients with atrial fibrillation","volume":"347","author":"Wyse","year":"2002","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.tcm.2025.01.002_bib0031","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa1105575","article-title":"Subclinical atrial fibrillation and the risk of stroke","volume":"366","author":"Healey","year":"2012","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.tcm.2025.01.002_bib0032","first-page":"1040","article-title":"Atrial fibrillation burden and short-term risk of stroke","volume":"8","author":"Turakhia","year":"2015","journal-title":"Circ: Arrhythm Electrophysiol"},{"issue":"19","key":"10.1016\/j.tcm.2025.01.002_bib0033","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1136\/heartjnl-2020-316977","article-title":"Atrial fibrillation and the prothrombotic state: revisiting Virchow's triad in 2020","volume":"106","author":"Ding","year":"2020","journal-title":"Heart"},{"issue":"7","key":"10.1016\/j.tcm.2025.01.002_bib0034","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1001\/jama.2023.27188","article-title":"Apixaban to prevent recurrence after cryptogenic stroke in patients with atrial cardiopathy: the ARCADIA randomized clinical trial","volume":"331","author":"Kamel","year":"2024","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.tcm.2025.01.002_bib0035","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1093\/cvr\/cvab283","article-title":"Utilizing biomarkers in atrial fibrillation: the pros and cons","volume":"118","author":"Ding","year":"2022","journal-title":"Cardiovasc Res"},{"issue":"3","key":"10.1016\/j.tcm.2025.01.002_bib0036","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1161\/CIRCIMAGING.109.865683","article-title":"Left atrial strain and strain rate in patients with paroxysmal and persistent atrial fibrillation: relationship to left atrial structural remodeling detected by delayed-enhancement MRI","volume":"3","author":"Kuppahally","year":"2010","journal-title":"Circ Cardiovasc Imaging"},{"issue":"3","key":"10.1016\/j.tcm.2025.01.002_bib0037","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1055\/s-0040-1716408","article-title":"The 4S-AF scheme (Stroke Risk; Symptoms; Severity of Burden; Substrate): a novel approach to In-depth characterization (Rather than Classification) of atrial fibrillation","volume":"121","author":"Potpara","year":"2021","journal-title":"Thromb Haemost"},{"issue":"2","key":"10.1016\/j.tcm.2025.01.002_bib0038","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/europace\/euab202","article-title":"Characterization of atrial fibrillation in real-world patients: testing the 4S-AF scheme in the Spanish and French cohorts of the EORP-AF Long-Term General Registry","volume":"24","author":"Rivera-Caravaca","year":"2022","journal-title":"Europace"},{"key":"10.1016\/j.tcm.2025.01.002_bib0039","article-title":"Practical approach to atrial cardiomyopathy characterization in patients with atrial fibrillation","author":"Rosa","year":"2024","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"issue":"13","key":"10.1016\/j.tcm.2025.01.002_bib0040","doi-asserted-by":"crossref","DOI":"10.4244\/EIJ-D-22-00627","article-title":"Left atrial appendage occlusion","volume":"18","author":"Holmes","year":"2023","journal-title":"EuroIntervention"},{"issue":"2","key":"10.1016\/j.tcm.2025.01.002_bib0041","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0003-4975(95)00887-X","article-title":"Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation","volume":"61","author":"Blackshear","year":"1996","journal-title":"Ann Thorac Surg"},{"issue":"9689","key":"10.1016\/j.tcm.2025.01.002_bib0042","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0140-6736(09)61343-X","article-title":"Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial","volume":"374","author":"Holmes","year":"2009","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.tcm.2025.01.002_bib0043","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1001\/jama.2014.3","article-title":"Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: tthe DECAAF study","volume":"311","author":"Marrouche","year":"2014","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.tcm.2025.01.002_bib0044","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American college of cardiology\/american heart association joint committee on clinical practice guidelines","volume":"149","author":"Joglar","year":"2024","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.tcm.2025.01.002_bib0045","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1055\/s-0041-1739411","article-title":"2021 focused update consensus guidelines of the asia pacific heart rhythm society on stroke prevention in atrial fibrillation: executive summary","volume":"122","author":"Chao","year":"2022","journal-title":"Thromb Haemost"},{"issue":"1","key":"10.1016\/j.tcm.2025.01.002_bib0046","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1186\/s12877-019-1390-x","article-title":"Being in good hands\": next of kin's perceptions of continuity of care in patients with heart failure","volume":"19","author":"Ostman","year":"2019","journal-title":"BMC geriatr"},{"issue":"5","key":"10.1016\/j.tcm.2025.01.002_bib0047","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.chest.2018.07.040","article-title":"Antithrombotic therapy for atrial fibrillation: CHEST guideline and expert panel report","volume":"154","author":"Lip","year":"2018","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.tcm.2025.01.002_bib0048","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1055\/s-0040-1710014","article-title":"Female sex as a risk modifier for stroke risk in atrial fibrillation: using CHA2DS2-VASc versus CHA2DS2-VA for stroke risk stratification in atrial fibrillation: a note of caution","volume":"120","author":"Nielsen","year":"2020","journal-title":"Thromb Haemost"},{"issue":"10","key":"10.1016\/j.tcm.2025.01.002_bib0049","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.hlc.2018.06.1043","article-title":"National heart foundation of australia and the cardiac society of australia and new zealand: australian clinical guidelines for the diagnosis and management of atrial fibrillation 2018","volume":"27","author":"Brieger","year":"2018","journal-title":"Heart Lung Circ"},{"issue":"2","key":"10.1016\/j.tcm.2025.01.002_bib0050","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"issue":"20","key":"10.1016\/j.tcm.2025.01.002_bib0051","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1093\/eurheartj\/ehae198","article-title":"Ischaemic stroke in women with atrial fibrillation: temporal trends and clinical implications","volume":"45","author":"Teppo","year":"2024","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.tcm.2025.01.002_bib0052","doi-asserted-by":"crossref","first-page":"6728","DOI":"10.1038\/s41467-024-51193-0","article-title":"Risk of stroke in male and female patients with atrial fibrillation in a nationwide cohort","volume":"15","author":"Nielsen","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.tcm.2025.01.002_bib0053","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euae280","article-title":"Refining the CHA2DS2VASc risk stratification scheme: shall we drop the Sex Category criterion?","author":"Yoshimura","year":"2024","journal-title":"Europace"},{"key":"10.1016\/j.tcm.2025.01.002_bib0054","article-title":"Comparing CHA(2)DS(2)-VA and CHA(2)DS(2)-VASc scores for stroke risk stratification in patients with atrial fibrillation: a temporal trends analysis from the retrospective Finnish AntiCoagulation in Atrial Fibrillation (FinACAF) cohort","volume":"43","author":"Teppo","year":"2024","journal-title":"Lancet Reg Health Eur"},{"issue":"4","key":"10.1016\/j.tcm.2025.01.002_bib0055","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1055\/s-0043-1776394","article-title":"Sex as a risk factor for atrial fibrillation-related stroke","volume":"124","author":"Corica","year":"2024","journal-title":"Thromb Haemost"},{"issue":"12","key":"10.1016\/j.tcm.2025.01.002_bib0056","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1093\/qjmed\/hcu054","article-title":"Is female sex a risk factor for stroke and thromboembolism in patients with atrial fibrillation? A systematic review and meta-analysis","volume":"107","author":"Wagstaff","year":"2014","journal-title":"Qjm"},{"issue":"8","key":"10.1016\/j.tcm.2025.01.002_bib0057","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1161\/CIRCULATIONAHA.117.029081","article-title":"Female sex is a risk modifier rather than a risk factor for stroke in atrial fibrillation: sshould we use a CHA(2)DS(2)-VA score rather than CHA(2)DS(2)-VASc?","volume":"137","author":"Nielsen","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2025.01.002_bib0058","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehae198","article-title":"Ischaemic stroke in women with atrial fibrillation: temporal trends and clinical implications","author":"Teppo","year":"2024","journal-title":"Eur Heart J"},{"issue":"12","key":"10.1016\/j.tcm.2025.01.002_bib0059","first-page":"1847","article-title":"The 2020 canadian cardiovascular society\/canadian heart rhythm society comprehensive guidelines for the management of atrial fibrillation","volume":"36","author":"Andrade","year":"2020","journal-title":"Can J Cardiol"},{"issue":"20","key":"10.1016\/j.tcm.2025.01.002_bib0060","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1093\/eurheartj\/ehw054","article-title":"The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation","volume":"37","author":"Hijazi","year":"2016","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.tcm.2025.01.002_bib0061","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.124.038860","article-title":"Neuroglial biomarkers for risk assessment of ischemic stroke and other cardiovascular events in patients with atrial fibrillation not receiving oral anticoagulation","volume":"14","author":"Aulin","year":"2025","journal-title":"J Am Heart Assoc"},{"issue":"0039\u20132499","key":"10.1016\/j.tcm.2025.01.002_bib0062","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","article-title":"Atrial fibrillation as an independent risk factor for stroke: the Framingham Study","volume":"22","author":"Wolf","year":"1991","journal-title":"Stroke"},{"issue":"1540\u20138167","key":"10.1016\/j.tcm.2025.01.002_bib0063","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1111\/jce.12199","article-title":"Association of atrial fibrosis quantified using LGE-MRI with atrial appendage thrombus and spontaneous contrast on transesophageal echocardiography in patients with atrial fibrillation","volume":"24","author":"Akoum","year":"2013","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"14","key":"10.1016\/j.tcm.2025.01.002_bib0064","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2008.11.054","article-title":"Paroxysmal lone atrial fibrillation is associated with an abnormal atrial substrate: characterizing the \"second factor\"","volume":"53","author":"Stiles","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2025.01.002_bib0065","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1212\/WNL.0000000000007827","article-title":"Embolic stroke of undetermined source correlates to atrial fibrosis without atrial fibrillation","volume":"93","author":"Tandon","year":"2019","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.tcm.2025.01.002_bib0066","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1161\/STROKEAHA.111.000173","article-title":"Troponin T, N-terminal pro-B-type natriuretic peptide, and incidence of stroke: the atherosclerosis risk in communities study","volume":"44","author":"Folsom","year":"2013","journal-title":"Stroke"},{"issue":"12","key":"10.1016\/j.tcm.2025.01.002_bib0067","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1212\/WNL.0000000000003115","article-title":"Circulating biomarkers and incident ischemic stroke in the Framingham Offspring Study","volume":"87","author":"Shoamanesh","year":"2016","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.tcm.2025.01.002_bib0068","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1161\/01.STR.0000236840.00467.84","article-title":"Additive role of plasma von Willebrand factor levels to clinical factors for risk stratification of patients with atrial fibrillation","volume":"37","author":"Lip","year":"2006","journal-title":"Stroke"},{"issue":"10333","key":"10.1016\/j.tcm.2025.01.002_bib0069","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/S0140-6736(22)00456-1","article-title":"Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study","volume":"399","author":"Piccini","year":"2022","journal-title":"The Lancet"},{"key":"10.1016\/j.tcm.2025.01.002_bib0070","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehy013","article-title":"Fibrin clot properties independently predict adverse clinical outcome following acute coronary syndrome: a PLATO substudy","author":"Sumaya","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.tcm.2025.01.002_bib0071","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijcard.2019.09.053","article-title":"Coagulation factors and fibrinolytic activity in the left atrial appendage and other heart chambers in patients with atrial fibrillation: is there a local intracardiac prothrombotic state? (HEART-CLOT study)","volume":"301","author":"Bartus","year":"2020","journal-title":"Int J Cardiol"},{"issue":"10413","key":"10.1016\/j.tcm.2025.01.002_bib0072","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/S0140-6736(23)01689-6","article-title":"Effect of colchicine on perioperative atrial fibrillation and myocardial injury after non-cardiac surgery in patients undergoing major thoracic surgery (COP-AF): an international randomised trial","volume":"402","author":"Conen","year":"2023","journal-title":"Lancet"},{"issue":"Suppl M","key":"10.1016\/j.tcm.2025.01.002_bib0073","doi-asserted-by":"crossref","first-page":"M26","DOI":"10.1093\/eurheartj\/suaa165","article-title":"Prevention of stroke in patients with chronic coronary syndromes or peripheral arterial disease","volume":"22","author":"Parker","year":"2020","journal-title":"Eur Heart J Suppl"}],"container-title":["Trends in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173825000076?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173825000076?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T18:52:17Z","timestamp":1760640737000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1050173825000076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":73,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S1050173825000076"],"URL":"https:\/\/doi.org\/10.1016\/j.tcm.2025.01.002","relation":{},"ISSN":["1050-1738"],"issn-type":[{"value":"1050-1738","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Atrial fibrillation versus atrial myopathy in thrombogenesis: Two sides of the same coin?","name":"articletitle","label":"Article Title"},{"value":"Trends in Cardiovascular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tcm.2025.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}